Shanghai Mabgeek Biotech Co., Ltd.

Shanghai Mabgeek Biotech Co., Ltd. (also known as Hunan Mabgeek Biotech Co., Ltd.) was founded in 2016. It focuses on the independent research and commercialization of innovative antibody drugs for allergic inflammatory diseases and autoimmune diseases. The company has developed the TEADA antibody discovery platform and has a pipeline including MG-K10, a long-acting anti-IL-4Rα antibody, currently in Phase III clinical trials for moderate-to-severe atopic dermatitis.

Shanghai Mabgeek Biotech Co., Ltd. (also referred to as Hunan Mabgeek Biotech Co., Ltd.) was founded in 2016. The company focuses on allergic inflammatory diseases and autoimmune diseases, conducting independent research and development of innovative antibody drugs. Its founder, Dr. Zhang Chenghai, led the core team that has overseen the development and clinical application of more than ten innovative antibody drugs. The company has created the TEADA antibody discovery platform and has a pipeline including MG-K10, a long-acting anti-IL-4Rα antibody, which is in Phase III clinical trials for moderate-to-severe atopic dermatitis.

• MG-K10

  A long-acting anti-IL-4Rα humanized monoclonal antibody, currently in Phase III clinical trials for moderate-to-severe atopic dermatitis.

1. 1麦济生物 / 致力于创新抗体药物研发mabgeek.com
2. 2公司介绍_麦济生物mabgeek.com
3. 3产品管线_麦济生物mabgeek.com